Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)

Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)

Abstract Background Research in treatment of non-small cell lung cancer (NSCLC) has shown promising results with stereotactic ablative radiotherapy (SABR) of oligometastatic disease, wherein distant disease may be limited to one or a few distant organs by host factors. Traditionally, PET/CT has been...

Full description

Bibliographic Details
Main Authors: Inderdeep Dhaliwal, Shayan Kassirian, Michael A. Mitchell, Mehdi Qiabi, Andrew Warner, Alexander V. Louie, Harvey H. Wong, Christine M. McDonald, Jason Rajchgot, David A. Palma
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Cancer
Subjects:
Stereotactic ablative radiotherapy (SABR)
Non-small cell lung cancer (NSCLC)
Endobronchial ultrasound (EBUS)
Endoscopic ultrasound (EUS)
Oligometastatic disease
Online Access:https://doi.org/10.1186/s12885-022-09563-8

Internet

https://doi.org/10.1186/s12885-022-09563-8

Similar Items